Recent Trends in Genetics and Immunology

Image

Now-a-days, immunologists are striving hard to develop new therapies in the field of Immune Disorders. In particular, immunological findings have led to the development of highly effective immune-checkpoint inhibitors. Hence, they are being highlighted and improvised in disease treatment.

The purpose of this Research Topic is therefore to provide an up-to-date overview of immune processes and new therapies for Rheumatoid Arthritis and Type 1 diabetes mellitus in order to further stimulate the development of new and even more successful treatments.

Immunogenetics: Open Access are welcoming experts in the fields of Genetics as well as immunology to submit Research, review articles, case reports and short communication summarizing the latest insights into immune responses and/or therapies (immunological and non-immunological) of Immune disorders, including: Systemic Lupus Erythmatosus, Crohn's disease and Rheumatoid arthritis.

A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded online at Editorial Tracking System or forwarded to the Editorial Office at immunogenetics@eclinicalsci.com.

How we work:

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.

• A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.

• Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Color Art: In a world of black & white journal articles, high-quality full-color images make your article stand out from the crowd and tell a complete story, increasing readers and citations.

Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.

 

Media Contact:

Robert Solomon

Managing Editor

Immunogenetics: Open Access

E-mail: immunogenetics@eclinicalsci.com

Whatsapp: +1-504-608-239